Literature DB >> 2955554

Prolonged minor allograft survival in intravenously primed mice--a test of the veto hypothesis.

L L Johnson.   

Abstract

Experiments were performed to test the hypothesis that veto cells are responsible for the prolonged survival of minor allografts of skin that is observed in recipients primed intravenously with spleen cells from mice syngeneic with the skin donors. This prolonged survival was observed for each of several minor histocompatibility (H) antigens and is antigen-specific. Gamma radiation (3300 rads) abolished the ability of male spleen cells infused i.v. to delay the rejection of male skin grafts (H-Y antigen) on female recipients. However, depletion of Thy-1+ cells from the i.v. infusion failed to abolish the ability to prolong male skin graft survival. Furthermore, the prolonged survival accorded to B6 (H-2b) male skin grafts on CB6F1 (H-2b/H-2d) female recipients given i.v. infusions of B6 male spleen cells extended to BALB/c (H-2d) male skin grafts as well, indicating a lack of MHC restriction. Thus, prolongation of minor allograft survival by i.v. infusion of minor H antigen-bearing spleen cells appears not to depend on veto T cells that others have found to be responsible for the suppression of CTL generation (2, 3, 5).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2955554     DOI: 10.1097/00007890-198707000-00020

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

Review 1.  Treatment of an autoimmune disease with "classical" T cell veto: a proposal.

Authors:  U D Staerz; Y Qi
Journal:  J Clin Immunol       Date:  1999-07       Impact factor: 8.317

2.  Antigraft responses to the H-28c antigen by B6 and B6D2F1 mice.

Authors:  L L Johnson
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Decreased resistance to primary intravenous Cryptococcus neoformans infection in aged mice despite adequate resistance to intravenous rechallenge.

Authors:  K M Aguirre; G W Gibson; L L Johnson
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

4.  Hybrid antibody mediated veto of cytotoxic T lymphocyte responses.

Authors:  Y Qi; R Berg; M A Singleton; J E Debrick; U D Staerz
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.